| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 87.162 | 88.865 | 114.610 | 96.209 | 95.103 | 123.002 | 146.949 | 162.735 | 175.390 | 240.658 |
| Total Income - EUR | 87.252 | 88.865 | 114.610 | 96.364 | 95.103 | 123.003 | 146.950 | 162.736 | 175.390 | 240.659 |
| Total Expenses - EUR | 81.931 | 87.752 | 117.992 | 92.409 | 92.316 | 117.891 | 138.378 | 157.410 | 162.742 | 234.103 |
| Gross Profit/Loss - EUR | 5.320 | 1.113 | -3.382 | 3.956 | 2.787 | 5.112 | 8.572 | 5.326 | 12.649 | 6.556 |
| Net Profit/Loss - EUR | 4.469 | 224 | -4.528 | 2.992 | 1.836 | 4.169 | 7.103 | 3.698 | 10.895 | 542 |
| Employees | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Macofarm Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.580 | 0 | 0 | 17.339 | 17.003 | 17.151 | 17.405 | 16.677 | 18.696 | 38.942 |
| Current Assets | 36.564 | 46.455 | 39.184 | 45.544 | 44.646 | 52.315 | 68.163 | 76.323 | 79.251 | 104.498 |
| Inventories | 24.312 | 33.433 | 25.163 | 28.389 | 33.432 | 35.616 | 41.451 | 49.425 | 48.638 | 59.444 |
| Receivables | 10.810 | 6.373 | 12.399 | 15.701 | 10.974 | 15.045 | 24.673 | 26.386 | 18.886 | 16.496 |
| Cash | 1.442 | 6.649 | 1.621 | 1.454 | 241 | 1.655 | 2.038 | 512 | 11.727 | 28.559 |
| Shareholders Funds | 9.128 | 9.259 | 4.575 | 25.251 | 26.599 | 30.263 | 36.965 | 40.778 | 51.550 | 51.478 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 37.002 | 45.551 | 34.609 | 37.631 | 35.050 | 39.203 | 48.603 | 52.222 | 46.397 | 91.961 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Macofarm Med S.r.l.